Skip to content

Clinical trials

Completed Phase 3 Carcinoma, Renal Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 3 Status: Completed Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20033
20044
20053
20065
20074
20083
20092
20103
20113
20122
20131
20141
20151
20163
20174
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Pfizer5
Bayer4
Bristol-Myers Squibb4
Centre Leon Berard3
European Organisation for Research and Treatment of Cancer - EORTC3
AVEO Pharmaceuticals, Inc.2
GlaxoSmithKline2
Heidelberg Pharma AG2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell57
Kidney Neoplasms21
Neoplasms9
Neoplasm Metastasis5
Carcinoma, Hepatocellular2
Gastrointestinal Stromal Tumors2
Adrenocortical Carcinoma1
Anus Neoplasms1
Appendiceal Neoplasms1
Astrocytoma1

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.